MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham

C. Parker, M. Maher, J. Vice, L. Lieb, M. Dean (BIRMINGHAM, USA)

Meeting: 2023 International Congress

Abstract Number: 1883

Keywords: Occupational Therapy, Parkinson’s, Visuospatial deficits

Category: Physical Therapy, Speech Therapy, Rehabilitation

Objective: Assess usefulness of low vision occupational therapy (OT) in a small cohort of Parkinson’s disease (PD) patients.

Background: PD patients report vision-related symptoms more frequently than the general population.1 However, screening for low vision may not frequently occur at clinic visits, and the usefulness of low vision OT in the PD population has not been studied previously. We created a small pilot study that assessed the change in the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) after one session of low vision OT in PD patients.

Method: We enrolled 33 PD participants from 2020 – 2021, and all PD diagnoses were confirmed by a UAB Movement Disorders-trained Neurologist. Participants completed the Visual Impairments in Parkinson’s Disease Questionnaire (VIPD-Q) and received one session of low vision OT provided at UAB. The primary endpoint was change in R-SRAFVP from baseline to 6-month follow up. If baseline or follow up R-SRAFVP data was incomplete, those participants were removed from analysis. R-SRAFVP was compared with a paired-sample t-test and all other variables were compared with independent samples t-test. Statistical analysis was performed using SPSS version 28.0.1.1 (IBM Corp., Armonk, NY). Statistical significance was defined as p<0.05.

Results: Twenty-seven participants completed the baseline and 6-month follow up R-SRAFVP and were included in analysis. There was no significant change in R-SRAFVP at 6 months (p=0.341). There were trends towards significance if the patient had a lower VIPD score (p=0.081) or did not have previously diagnosed eye disease (p=0.199). Age or the presence of hallucinations did not predict significant change in the R-SRAFVP score.

Conclusion: There was no significant change in the R-SRAFVP after PD patients received one session of low vision OT. However, there were trends towards significance if the patient did not have a history of eye disease or had a lower VIPD score. This suggests that low vision OT may be more useful in PD patients with milder vision-related symptoms. Therefore, we recommend considering screening PD patients for visual symptoms and referring for low vision OT when symptoms are mild. This study was limited by a small sample size and potential investigator bias, and a larger study is needed to confirm these findings.

References: 1 – Borm CDJM, et al. Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire. Neurology. 2020 Apr 7;94(14):e1539-e1547.

To cite this abstract in AMA style:

C. Parker, M. Maher, J. Vice, L. Lieb, M. Dean. Low Vision Occupational Therapy for Parkinson’s Disease – A Pilot Study at the University of Alabama at Birmingham [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/low-vision-occupational-therapy-for-parkinsons-disease-a-pilot-study-at-the-university-of-alabama-at-birmingham/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/low-vision-occupational-therapy-for-parkinsons-disease-a-pilot-study-at-the-university-of-alabama-at-birmingham/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley